US › Healthcare

60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP)

US · Healthcare · Biotechnology

$0.99+7.47%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$207,898

Revenue YoY

+106.0%

Net profit

$-2.3M

EPS

$-0.90

EPS estimate

$-0.74

Net margin

-1,089.2%

EPS came in at -0.90 against a street estimate of -0.74 — a miss of 21.6%.

Key statistics

Market cap

$3.3M

Forward P/E

0.0

P/B

0.00

Book value

$-2.62

EPS (TTM)

$-2.73

52-week high

$7.36

52-week low

$0.90

50-day MA

$1.29

200-day MA

$2.17

Beta

2.54

Analyst view

Analysts rate 60 Degrees Pharmaceuticals, Inc. Common Stock a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $3.70.

Shareholding

Insiders

19.39%

Institutions

17.11%

Largest institutional holders

Fund	Stake
Kathmere Capital Management, LLC	22.79%
UBS Group AG	2.70%
Geode Capital Management, LLC	1.40%
Barclays PLC	0.16%
Goss Wealth Management LLC	0.00%
Advisor Group Holdings, Inc.	0.00%
Citigroup Inc	0.00%
Tower Research Capital LLC	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for 60 Degrees Pharmaceuticals, Inc. Common Stock — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.